| ²é¿´: 987 | »Ø¸´: 3 | |||
hdang2003ľ³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
GSKÖйúµÄÖÐÒ©Ñо¿²¿ÃŠת×Ô¶¡ÏãÔ° ÒÑÓÐ3È˲ÎÓë
|
|
Britain¡¯s biggest drug maker last week unveiled the outcome of a review of its 38 groups of scientists, known as Discovery Performance Units (DPU), saying it would close three units and open four. The Sunday Telegraph can reveal the new units will look at traditional Chinese medicines, investigating how their principles can be applied to making new, synthetic, molecules. ¡°Within our discovery organisation in China we have created a DPU that will marry traditional Chinese medicine with modern drug discovery and clinical efficacy,¡± said Moncef Slaoui, Glaxo¡¯s chairman of research and development. ¡°With modern technology we have the potential to yield new molecular entities with significant efficacy.¡± The new unit will be based in China ¨C Glaxo launched an R&D centre in Shanghai almost five years ago. With its pharmaceutical market forecast to mushroom to more than $100bn (?63.5bn) by 2015, China is one of the most important battlegrounds for drug companies facing pricing pressure and more competition from generics. Glaxo¡¯s move reflects a wish by drug companies to adapt their research to particular regions. Six years ago, AstraZeneca established a centre in China to study diseases prevalent in Asia, such as liver and stomach cancer, and lung conditions. Last October, Astra also said it planned to invest $200m in a new Chinese factory making intravenous and oral solid medicines. Astra¡¯s sales in emerging markets, including China, grew 10pc to $5.8bn last year, while Glaxo¡¯s Asia Pacific revenues grew 7pc to ?1.8bn. ¸öÈËÈÏΪÖÐÒ©µÄǰ;¿Ï¶¨ÊǹâÃ÷µÄ£¬ÉõÖÁºÃÓÚÎ÷Ò©£¬µ«ÔÚ¹ýÈ¥µÄÉÏǧÄêʱ¼äÀÖÐÒ©µÄ·¢Õ¹²½·¥¼¸½üÍ£ÖÍ£¬ÊDz»ÊÇÖÐÒ©µÄ·¢Õ¹µÃ¸Ä±ä˼·£¿´óÐÍÒ©ÆóµÄ½éÈ뽫»áÊǸöºÃµÄ¿ª¶Ë¡£ |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
¼ºÍª¿É¿É¼î¹ýÑõ»¯ÔÓÖÊÏÞ¶È
ÒѾÓÐ2È˻ظ´
ÇóÖúIsoeugenolÖÊÁ¿±ê×¼
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ299È˻ظ´
Gliclazide
ÒѾÓÐ0È˻ظ´
ÈûÌæÅÉ/àçÌæßߣ¨Thiotepa£© ÖÊÁ¿¿ØÖÆ
ÒѾÓÐ16È˻ظ´
ÓÐûÓдóÀпÉÒÔ°ïæ²éÏÂTrijardy XRºÍQternmet XRÀúÄêÏúÊÛÊý¾Ýѽ
ÒѾÓÐ0È˻ظ´
õ£°·Ë®½âÇóÖú
ÒѾÓÐ11È˻ظ´
ÖÐÒ©²Ä±ê׼Ŀ¼´óÈ«llp2026£¨º¬¸÷Ê¡ÊÐÖÐÒ©²ÄºÍÅÚÖÆ¹æ·¶£©
ÒѾÓÐ0È˻ظ´
õ£°·ÍÑÒÒõ£»ù
ÒѾÓÐ13È˻ظ´
¼û¿¯¿ìµÄÖÐÎĺËÐÄÆÚ¿¯
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÄæÏòÁµ°®Êõ¡¾×ªÔØ¡¿
ÒѾÓÐ28È˻ظ´
ÖÐÒ©»ºÊÍÖÆ¼ÁÑо¿ÏÖ×´
ÒѾÓÐ8È˻ظ´
ת»¯Âʽӽü100%µÄ·´Ó¦ÈçºÎ¿¼²ìÀ©É¢¶Ô¶¯Á¦Ñ§µÄÓ°Ïì
ÒѾÓÐ3È˻ظ´
ÖÐÑëÃñ×åÉÙÊýÃñ×åÒ½Ò©Ñо¿Ôº£¨985£©ºÍÕã½ÖÐÒ½Ò©´óѧ£¨ÆÕͨ¶þ±¾£©£¬Äĸö¸üºÃ
ÒѾÓÐ8È˻ظ´
Çë½Ì×ø±êÓë¾Î³¶ÈµÄת»»
ÒѾÓÐ1È˻ظ´
¡¾×ªÔØ¡¿¼¸¸öÓеÀÀíµÄС¹ÊÊ£¬ÖµµÃÒ»¿´
ÒѾÓÐ99È˻ظ´
¡¾×ªÌû¡¿½ø¿ÚÖÖ×ÓÏÈÃâ·Ñºó¸ß¼Û ÎÒ¹úÖÖÒµ¸ÃÈçºÎ·´Ë¼
ÒѾÓÐ23È˻ظ´
1994yw
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 1708.3
- É¢½ð: 105
- Ìû×Ó: 646
- ÔÚÏß: 79.5Сʱ
- ³æºÅ: 1242523
- ×¢²á: 2011-03-23
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
2Â¥2012-02-21 15:19:43
weixiaogang
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 24 (СѧÉú)
- ½ð±Ò: 3639.3
- É¢½ð: 5
- ºì»¨: 2
- Ìû×Ó: 711
- ÔÚÏß: 193Сʱ
- ³æºÅ: 1470249
- ×¢²á: 2011-11-01
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ

3Â¥2012-02-21 16:54:22
rexunbj
гæ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 142.2
- É¢½ð: 294
- ºì»¨: 10
- Ìû×Ó: 162
- ÔÚÏß: 87.1Сʱ
- ³æºÅ: 931354
- ×¢²á: 2009-12-21
- רҵ: ºÏ³ÉÒ©Îﻯѧ
4Â¥2012-02-21 18:03:40













»Ø¸´´ËÂ¥
1994yw